Graduate School of Biomedical Sciences

Graduate School of Biomedical Sciences

Rowan University and Bamboo Therapeutics, Inc. have entered into an asset transfer agreement to commercialize a novel gene therapy for the treatment of Canavan disease.

In four sunshine-filled days across six ceremonies, degrees were conferred upon more than 3,200 members of the Class of 2015 during Rowan University’s first-ever Commencement Week, May 12-15.

Jack Annunziato, of Manalapan, NJ, called it “a phenomenal day.”

Innately curious, Minshi Wang finds a most excellent adventure en route to her doctorate from RowanGSBS.
The Rowan Innovation Venture Fund is now accepting applications for funding from researchers, entrepreneurs, business owners and others in South Jersey, including Rowan faculty, students and alumni as well as area residents.
#RowanGIVES Day inspired 450 donors to give $63,629 to Rowan to support the Rowan Future Fund, University programs and scholarships.
Paola Leone, PhD, a professor of Cell Biology at RowanSOM, has been awarded a three-year, $477,000 grant from the National Institute of Neurological Disorders and Stroke (NINDS) to develop a stem cell-based therapy for Canavan disease, a rare but devastating neurological disorder in children that typically takes a child’s life by age 10.
Researchers at RowanSOM have discovered a molecular 'switch' that controls replication and transcription of mitochondria DNA.

With an office painted turquoise blue, science and art books stacked on bookshelves, and sculptures and figurines piled high on the shelf opposite her desk, Amanda S.

Rowan University has appointed long-time higher education administrator and innovator Carl “Tobey” Oxholm III as executive vice president for Administration and Strategic Advancement.

Pages